{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:38:48Z","timestamp":1648737528543},"reference-count":0,"publisher":"Frontline Medical Communications, Inc.","issue":"38 (10)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,15]]},"DOI":"10.12788\/fp.0193","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T21:11:08Z","timestamp":1635455468000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Adverse Events With Vancomycin Diluted in Normal Saline vs Dextrose 5%"],"prefix":"10.12788","author":[{"given":"Robert","family":"Ross","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5043","published-online":{"date-parts":[[2021,10,15]]},"container-title":["Federal Practitioner"],"original-title":[],"link":[{"URL":"https:\/\/cdn.mdedge.com\/files\/s3fs-public\/issues\/articles\/fdp03810468.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T21:11:09Z","timestamp":1635455469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdedge.com\/fedprac\/article\/247215\/mixed-topics\/comparison-adverse-events-vancomycin-diluted-normal-saline-vs"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":0,"journal-issue":{"issue":"38 (10)","published-online":{"date-parts":[[2021,10,15]]},"published-print":{"date-parts":[[2021,10,15]]}},"URL":"https:\/\/doi.org\/10.12788\/fp.0193","relation":{},"subject":[],"published":{"date-parts":[[2021,10,15]]}}}